UnitedHealth Group Rating Reiterated by TheStreet (UNH)
UnitedHealth Group (NYSE:UNH)‘s stock had its “buy” rating restated by equities research analysts at TheStreet in a research note issued to investors on Friday, AnalystRatings.NET reports.
The analysts wrote, “UnitedHealth Group (UNH) has been reiterated by TheStreet Ratings as a buy with a ratings score of A-. The company’s strengths can be seen in multiple areas, such as its solid stock price performance, growth in earnings per share, revenue growth, attractive valuation levels and largely solid financial position with reasonable debt levels by most measures. We feel these strengths outweigh the fact that the company shows weak operating cash flow.”
Shares of UnitedHealth Group (NYSE:UNH) traded down 0.71% on Friday, hitting $72.28. The stock had a trading volume of 4,291,488 shares. UnitedHealth Group has a 52-week low of $52.51 and a 52-week high of $77.33. The stock has a 50-day moving average of $73.46 and a 200-day moving average of $72.33. The company has a market cap of $73.292 billion and a P/E ratio of 13.24.
UnitedHealth Group (NYSE:UNH) last announced its earnings results on Wednesday, January 15th. The company reported $1.41 earnings per share for the quarter, beating the analysts’ consensus estimate of $1.40 by $0.01. The company had revenue of $31.10 billion for the quarter, compared to the consensus estimate of $31.06 billion. During the same quarter in the prior year, the company posted $1.20 earnings per share. The company’s quarterly revenue was up 8.2% on a year-over-year basis. Analysts expect that UnitedHealth Group will post $5.60 EPS for the current fiscal year.
In other UnitedHealth Group news, Director William Ballard, Jr. sold 10,000 shares of UnitedHealth Group stock in a transaction dated Tuesday, January 21st. The shares were sold at an average price of $73.05, for a total transaction of $730,500.00. Following the completion of the transaction, the director now directly owns 65,042 shares in the company, valued at approximately $4,751,318. The transaction was disclosed in a legal filing with the Securities & Exchange Commission, which is available at this link.
Other equities research analysts have also recently issued reports about the stock. Analysts at Morgan Stanley reiterated an “overweight” rating on shares of UnitedHealth Group in a research note to investors on Wednesday, January 22nd. Separately, analysts at Monness Crespi & Hardt downgraded shares of UnitedHealth Group from a “neutral” rating to a “sell” rating in a research note to investors on Tuesday, January 21st. They now have a $59.00 price target on the stock. Finally, analysts at Zacks reiterated a “neutral” rating on shares of UnitedHealth Group in a research note to investors on Friday, January 17th. They now have a $76.00 price target on the stock. One analyst has rated the stock with a sell rating, five have assigned a hold rating, fifteen have issued a buy rating and two have assigned a strong buy rating to the stock. The company has an average rating of “Buy” and an average target price of $78.16.
UnitedHealth Group Incorporated (NYSE:UNH) diversified health and well-being company.
Get Analysts' Upgrades and Downgrades via Email - Stay on top of analysts' coverage with Analyst Ratings Network's FREE daily email newsletter that provides a concise list of analysts' upgrades and downgrades. Click here to register now.